Belka C - Search Results

1

Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study.

Corradini S, Bauerfeind I, Belka C, Braun M, Combs SE, Eckel R, Harbeck N, Hölzel D, Kiechle M, Niyazi M, Engel J. Corradini S, et al. Among authors: belka c. Radiother Oncol. 2017 Jan;122(1):2-10. doi: 10.1016/j.radonc.2016.08.018. Epub 2016 Sep 15. Radiother Oncol. 2017. PMID: 27641786

2

Impact of localized radiotherapy on blood immune cells counts and function in humans.

Belka C, Ottinger H, Kreuzfelder E, Weinmann M, Lindemann M, Lepple-Wienhues A, Budach W, Grosse-Wilde H, Bamberg M. Belka C, et al. Radiother Oncol. 1999 Feb;50(2):199-204. doi: 10.1016/s0167-8140(98)00130-3. Radiother Oncol. 1999. PMID: 10368044

3

Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma.

Welz S, Schmid A, Hehr T, Schulze K, Feldmann HJ, Budach W, Bamberg M, Belka C. Welz S, et al. Among authors: belka c. Radiother Oncol. 2005 Dec;77(3):267-70. doi: 10.1016/j.radonc.2005.07.004. Epub 2005 Sep 9. Radiother Oncol. 2005. PMID: 16154220

4

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

5

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

6

Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.

Handrick R, Ganswindt U, Faltin H, Goecke B, Daniel PT, Budach W, Belka C, Jendrossek V. Handrick R, et al. Among authors: belka c. Radiother Oncol. 2009 Mar;90(3):413-21. doi: 10.1016/j.radonc.2008.10.021. Epub 2008 Nov 27. Radiother Oncol. 2009. PMID: 19038466

7

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Strahlenther Onkol. 2009 Jan;185(1):8-18. doi: 10.1007/s00066-009-1856-4. Epub 2009 Feb 18. Strahlenther Onkol. 2009. PMID: 19224142

8

Evidence-based radiation oncology: oesophagus.

Berger B, Belka C. Berger B, et al. Among authors: belka c. Radiother Oncol. 2009 Aug;92(2):276-90. doi: 10.1016/j.radonc.2009.02.019. Epub 2009 Apr 15. Radiother Oncol. 2009. PMID: 19375187 Review.

9

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Oncol Rep. 2009 Jun;21(6):1455-60. doi: 10.3892/or_00000374. Oncol Rep. 2009. PMID: 19424623

10

Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

Marini P, Budach W, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. Marini P, et al. Among authors: belka c. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):198-202. doi: 10.1016/j.ijrobp.2009.04.038. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters